Cambridge Trust Co. trimmed its position in Danaher Corporation (NYSE:DHR) by 0.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 149,251 shares of the conglomerate’s stock after selling 517 shares during the quarter. Cambridge Trust Co.’s holdings in Danaher Corporation were worth $12,596,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Lee Danner & Bass Inc. increased its holdings in shares of Danaher Corporation by 0.4% in the 1st quarter. Lee Danner & Bass Inc. now owns 2,635 shares of the conglomerate’s stock valued at $225,000 after acquiring an additional 10 shares during the last quarter. Norway Savings Bank increased its holdings in shares of Danaher Corporation by 0.4% in the 2nd quarter. Norway Savings Bank now owns 2,238 shares of the conglomerate’s stock valued at $189,000 after acquiring an additional 10 shares during the last quarter. First Financial Corp IN increased its holdings in shares of Danaher Corporation by 0.8% in the 2nd quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock valued at $230,000 after acquiring an additional 21 shares during the last quarter. Guardian Life Insurance Co. of America increased its holdings in shares of Danaher Corporation by 1.0% in the 1st quarter. Guardian Life Insurance Co. of America now owns 2,356 shares of the conglomerate’s stock valued at $202,000 after acquiring an additional 24 shares during the last quarter. Finally, Assetmark Inc. increased its holdings in shares of Danaher Corporation by 0.5% in the 1st quarter. Assetmark Inc. now owns 6,622 shares of the conglomerate’s stock valued at $566,000 after acquiring an additional 30 shares during the last quarter. Institutional investors and hedge funds own 75.75% of the company’s stock.

A number of equities research analysts have recently weighed in on the company. J P Morgan Chase & Co reiterated an “overweight” rating and issued a $95.00 price target on shares of Danaher Corporation in a report on Friday, September 8th. Jefferies Group LLC reiterated a “buy” rating and issued a $95.00 price target on shares of Danaher Corporation in a report on Friday, August 4th. BidaskClub downgraded Danaher Corporation from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 1st. Zacks Investment Research upgraded Danaher Corporation from a “hold” rating to a “buy” rating and set a $91.00 price target for the company in a report on Friday, July 28th. Finally, Wells Fargo & Company reiterated a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $92.72.

In other news, insider William King sold 7,458 shares of the stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the transaction, the insider now directly owns 18,245 shares of the company’s stock, valued at approximately $1,513,787.65. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the transaction, the insider now directly owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The disclosure for this sale can be found here. Over the last three months, insiders sold 71,496 shares of company stock valued at $5,916,223. 12.20% of the stock is currently owned by insiders.

Danaher Corporation (NYSE:DHR) opened at 87.24 on Thursday. The company’s 50-day moving average price is $82.11 and its 200-day moving average price is $84.15. The firm has a market cap of $60.60 billion, a price-to-earnings ratio of 27.85 and a beta of 1.03. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.01.

Danaher Corporation (NYSE:DHR) last issued its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The business had revenue of $4.51 billion during the quarter, compared to analysts’ expectations of $4.50 billion. During the same period in the prior year, the firm posted $0.90 EPS. Danaher Corporation’s quarterly revenue was up 6.3% compared to the same quarter last year. Analysts predict that Danaher Corporation will post $3.95 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be issued a $0.14 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.64%. Danaher Corporation’s payout ratio is presently 17.83%.

COPYRIGHT VIOLATION NOTICE: “Danaher Corporation (DHR) Shares Sold by Cambridge Trust Co.” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/14/danaher-corporation-dhr-shares-sold-by-cambridge-trust-co.html.

Danaher Corporation Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.